Additionally, in vitro experiments as well as data from Oncomine database and Cancer Cell Line Encyclopedia (CCLE) have elucidated a strong association between mortalin expression and serous ovarian carcinoma suggesting its promise use as a diagnostic biomarker in serous ovarian carcinoma [119]. The gene discussed is HSPA9; the disease is ovarian serous carcinoma.